← Leaderboards
Christina Marie Zeina
Harvard Medical School
$134,064
Attributed
$134,064
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$134,064 · 1
By mechanism
F30$134,064 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Steven P Gygi$23,279,525
- Hao Wu$47,906,316
- Marc W Kirschner$55,400,682
- Michaela Ulrike Gack$22,395,027
- Wei-Dong Yao$11,300,934
Others in their field
Other Rising Stars on “Degradation Pathway”
- Edwin Manuel · Beckman Research Institute/City Of Hope$3,382,655
- Yanhong Guo · University Of Michigan At Ann Arbor$3,191,698
- Jacob Matthew Allen · University Of Illinois At Urbana-Champaign$2,622,833
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Andrei A Vakhtin · Lovelace Biomedical Research Institute$2,171,443
- Richard Johnson · Saros Therapeutics Inc$2,046,919
Research focus
Degradation PathwayAlpha HelixAffinityDana-Farber Cancer InstituteAnti-CancerAntineoplastic AgentsApicalApoptosisAdductBindingBinding SitesBiochemicalBiologyBortezomibCancer CareCancer CellCancer TherapyCell ProliferationCellsCell SurvivalChargeChemoresistanceComplexDesign
Grant awards (3)
Targeting the E1 Control Point of Protein Ubiquitination in Cancer$53,974
F30 · FY2025 · CA · contact PI
Targeting the E1 Control Point of Protein Ubiquitination in Cancer$41,156
F30 · FY2024 · CA · contact PI
Targeting the E1 Control Point of Protein Ubiquitination in Cancer$38,934
F30 · FY2022 · CA · contact PI